References
- Ball NJ, Cowan BJ, Hashimoto SA. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis: a study of 12 cases. J Cutan Pathol 2009;36:331–337
- Gaines AR, Varricchio F. Interferon beta-1b injection site reactions and necroses. Mult Scler 1998;4:70--73
- Nakamura Y, Kawachi Y, Furuta J, Otsuka F. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection. Eur J Dermatol 2008;18:579–582
- Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-1b in MS: results of an open label trial. Neurology 1996;46:552–554
- Cnudde F, Gharakhanian S, Luboinski J, et al. Cutaneous local necrosis following interferon injections. Int J Dermatol 1991;30:147
- Kontochristopoulos G, Stavrinos C, Aroni K, Tassopoulos NC. Cutaneous necrosis by subcutaneous injection of interferon-a in a patient with chronic type B hepatitis. J Hepatol 1996;25:271
- Pachler C, Ikeoka D, Plank J, et al. Subcutaneous adipose tissue exerts proinflammatory cytokines after minimal trauma in humans. Am J Physiol Endocrinol Metab 2007;293:690–696